Best Practice & Research Clinical Anaesthesiology
Volume 21, Issue 2 , Pages 221-239 , June 2007

Alternatives to allogeneic blood transfusions

  • Andreas Pape (Dr. med.)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49 69 6301 83627; Fax: +49 69 6301 83768.

References 

  1. Goodnough LT. Risks of blood transfusion. Critical Care Medicine. 2003;31:S678–S686
  2. Madjdpour C, Heindl V, Spahn DR. Risks, benefits, alternatives and indications of allogenic blood transfusions. Minerva Anestesiologica. 2006;72:283–298
  3. Hebert PC, Wells GA, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. The New England Journal of Medicine. 1999;340:409–417
  4. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA: The Journal of the American Medical Association. 2002;288:1499–1507
  5. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT Study: Anemia and blood transfusion in the critically ill–current clinical practice in the United States. Critical Care Medicine. 2004;32:39–52
  6. Taylor RW, O'Brien J, Trottier SJ, et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Critical Care Medicine. 2006;34:2302–2308
  7. Palmieri TL, Caruso DM, Foster KN, et al. Effect of blood transfusion on outcome after major burn injury: a multicenter study. Critical Care Medicine. 2006;34:1602–1607
  8. Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfusion Medicine (Oxford, England). 2003;13:205–218
  9. Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet. 2003;361:161–169
  10. Messmer KF. Acceptable hematocrit levels in surgical patients. World Journal of Surgery. 1987;11:41–46
  11. Spahn DR, Casutt M. Eliminating blood transfusions: new aspects and perspectives. Anesthesiology. 2000;93:242–255
  12. Habler OP, Messmer KF. The physiology of oxygen transport. Transfusion Science. 1997;18:425–435
  13. Cain SM. Oxygen delivery and uptake in dogs during anemic and hypoxic hypoxia. Journal of Applied Physiology. 1977;42:228–234
  14. Meier JM, Kemming GI, Kisch-Wedel H, et al. Hyperoxic ventilation reduces 6-hour mortality at the critical hemoglobin concentration. Anesthesiology. 2004;100:70–76
  15. Fontana JL, Welborn L, Mongan PD, et al. Oxygen consumption and cardiovascular function in children during profound intraoperative normovolemic hemodilution. Anesthesia and Analgesia. 1995;80:219–225
  16. Zollinger A, Hager P, Singer T, et al. Extreme hemodilution due to massive blood loss in tumor surgery. Anesthesiology. 1997;87:985–987
  17. van Citters RL, Franklin DL. Cardiovascular performance of Alaska sled dogs during exercise. Circulation Research. 1969;24:33–42
  18. Madjdpour C, Spahn DR, Weiskopf RB. Anemia and perioperative red blood cell transfusion: a matter of tolerance. Critical Care Medicine. 2006;34:S102–S108
  19. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348:1055–1060
  20. van der Linden P, De Hert S, Mathieu N, et al. Tolerance to acute isovolemic hemodilution. Effect of anesthetic depth. Anesthesiology. 2003;99:97–104
  21. Vernon DD, Witte MK. Effect of neuromuscular blockade on oxygen consumption and energy expenditure in sedated, mechanically ventilated children. Critical Care Medicine. 2000;28:1569–1571
  22. Perez-de-Sa V, Roscher R, Cunha-Goncalves D, et al. Mild hypothermia has minimal effects on the tolerance to severe progressive normovolemic anemia in Swine. Anesthesiology. 2002;97:1189–1197
  23. Habler OP, Messmer KF. Hyperoxaemia in extreme haemodilution. British Journal of Anaesthesia. 1998;81(supplement 1):79–82
  24. Pape A, Meier J, Kertscho H, et al. Hyperoxic ventilation increases the tolerance of acute normovolemic anemia in anesthetized pigs. Critical Care Medicine. 2006;34:1475–1482
  25. Habler OP, Kleen MS, Hutter JW, et al. Hemodilution and intravenous perflubron emulsion as an alternative to blood transfusion: effects on tissue oxygenation during profound hemodilution in anesthetized dogs. Transfusion. 1998;38:145–155
  26. Habler OP, Kleen MS, Hutter JW, et al. Effects of hyperoxic ventilation on hemodilution-induced changes in anesthetized dogs. Transfusion. 1998;38:135–144
  27. Habler O. Cardiac high-risk patients: From ‘permissive’ to ‘deliberate’ anemia. Critical Care Medicine. 2005;33:2434–2435
  28. Vamvakas EC, Pineda AA. Autologous transfusion and other approaches to reduce allogeneic blood exposure. Baillière's Best Practice & Research. Clinical Haematology. 2000;13:533–547
  29. Karger R, Kretschmer V. Modern concepts of autologous haemotherapy. Transfusion and Apheresis Science. 2005;32:185–196
  30. Rogers BA, Johnstone DJ. Audit on the efficient use of cross-matched blood in elective total hip and total knee replacement. Annals of the Royal College of Surgeons of England. 2006;88:199–201
  31. Hutton B, Fergusson D, Tinmouth A, et al. Transfusion rates vary significantly amongst Canadian medical centres. Canadian Journal of Anaesthesia. 2005;52:581–590
  32. Keating EM, Meding JB. Perioperative blood management practices in elective orthopaedic surgery. The Journal of the American Academy of Orthopaedic Surgeons. 2002;10:393–400
  33. Habler OP, Messmer KF. Verfahren zur Reduktion von Fremdblut in der operativen Medizin. Anaesthesist. 1997;46:915–926
  34. Shander A. Surgery without blood. Critical Care Medicine. 2003;31:S708–S714
  35. Carless P, Moxey A, O'Connell D, Henry D. Autologous transfusion techniques: a systematic review of their efficacy. Transfusion Medicine (Oxford, England). 2004;14:123–144
  36. Messmer K, Sunder-Plassmann L. Hemodilution. Progress in Surgery. 1974;13:208–245
  37. Murray D. Acute normovolemic hemodilution. European Spine Journal. 2004;13:S72–S75
  38. Weiskopf RB. Efficacy of acute normovolemic hemodilution assessed as a function of fraction of blood volume lost. Anesthesiology. 2001;94:439–446
  39. Matot I, Scheinin O, Jurim O, Eid A. Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology. 2002;97:794–800
  40. Wong JC, Torella F, Haynes SL, et al. Autologous versus allogeneic transfusion in aortic surgery: a multicenter randomized clinical trial. Annals of Surgery. 2002;235:145–151
  41. Bennett J, Haynes S, Torella F, et al. Acute normovolemic hemodilution in moderate blood loss surgery: a randomized controlled trial. Transfusion. 2006;46:1097–1103
  42. Terada N, Arai Y, Matsuta Y, et al. Acute normovolemic hemodilution for radical prostatectomy: can it replace preoperative autologous blood transfusion?. International Journal of Urology. 2001;8:149–152
  43. Habler OP, Schwenzer K, Zimmer K, et al. Effects of standardized acute normovolemic hemodilution on intraoperative allogeneic blood transfusion in patients undergoing major maxillofacial surgery. International Journal of Oral and Maxillofacial Surgery. 2004;33:467–475
  44. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesthesia and Analgesia. 1998;86:9–15
  45. Segal JB, Blasco-Colmenares E, Norris EJ, Guallar E. Preoperative acute normovolemic hemodilution: a meta-analysis. Transfusion. 2004;44:632–644
  46. Monk TG, Goodnough LT, Brecher ME, et al. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy. Anesthesiology. 1999;91:24–33
  47. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology. 2006;105:198–208
  48. Cuenca J, Garcia-Erce JA, Martinez F, et al. Perioperative intravenous iron, with or without erythropoietin, plus restrictive transfusion protocol reduce the need for allogeneic blood after knee replacement surgery. Transfusion. 2006;46:1112–1119
  49. Andrews CM, Lane DW, Bradley JG. Iron pre-load for major joint replacement. Transfusion Medicine (Oxford, England). 1997;7:281–286
  50. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood. 2000;96:823–833
  51. Chun TY, Martin S, Lepor H. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy. Urology. 1997;50:727–732
  52. Dai B, Wang L, Djaiani G, Mazer CD. Continuous and discontinuous cell-washing autotransfusion systems. Journal of Cardiothoracic and Vascular Anesthesia. 2004;18:210–217
  53. Waters JH. Indications and contraindications of cell salvage. Transfusion. 2004;44:40S–44S
  54. Bowley DM, Barker P, Boffard KD. Intraoperative Blood Salvage in Penetrating Abdominal Trauma: a Randomised, Controlled Trial. World Journal of Surgery. 2006;30:1074–1080
  55. Hansen E, Bechmann V, Altmeppen J. Intraoperative blood salvage in cancer surgery: safe and effective?. Transfusion and Apheresis Science. 2002;27:153–157
  56. Beck-Schimmer B, Romero B, Booy C, et al. Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion. European Journal of Anaesthesiology. 2004;21:46–52
  57. Catling S, Joels L. Cell salvage in obstetrics: the time has come. BJOG: an International Journal of Obstetrics and Gynaecology. 2005;112:131–132
  58. Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology. 2000;92:1531–1536
  59. Huet C, Salmi LR, Fergusson D, et al. A meta-analysis of the effectiveness of cell salvage to minimize perioperative allogeneic blood transfusion in cardiac and orthopedic surgery. International Study of Perioperative Transfusion (ISPOT) Investigators. Anesthesia and Analgesia. 1999;89:861–869
  60. Gohel MS, Bulbulia RA, Slim FJ, et al. How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses). Annals of the Royal College of Surgeons of England. 2005;87:3–14
  61. Habler OP, Pape A, Meier J, Zwissler B. Künstliche Sauerstoffträger als Alternative zur Bluttransfusion. Anaesthesist. 2005;54:741–754
  62. Spahn DR, Kocian R. Artificial O2 carriers: status in 2005. Current Pharmaceutical Design. 2005;11:4099–4114
  63. Riess JG. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology. 2005;33:47–63
  64. Spahn DR, Willimann PF, Faithfull NS. Die Wirksamkeit der Augmentierten Akuten Normovolämen Hämodilution (A-ANH™). Anaesthesist. 2001;50(supplement 1):S49–S54
  65. Spahn DR, Kocian R. The place of artificial oxygen carriers in reducing allogeneic blood transfusions and augmenting tissue oxygenation. Canadian Journal of Anaesthesia. 2003;50:S41–S47
  66. Habler OP, Kleen MS, Hutter JW, et al. IV perflubron emulsion versus autologous transfusion in severe normovolemic anemia: effects on left ventricular perfusion and function. Research in Experimental Medicine. 1998;197:301–318
  67. Frumento RJ, Mongero L, Naka Y, Benett-Guerrero E. Preserved gastric tonometric variables in cardiac surgical patients administered intravenous perflubron emulsion. Anesthesia and Analgesia. 2002;94:809–814
  68. Spahn DR, van BR, Theilmeier G, et al. Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group. Anesthesiology. 1999;91:1195–1208
  69. Spahn DR, Waschke KF, Standl T, et al. Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study. Anesthesiology. 2002;97:1338–1349
  70. Pape A, Kertscho H, Meier J, et al. Overview of artificial O2 carriers. ISBT Science Series. 2006;1(1):152–160
  71. Moore EE. Blood substitutes: the future is now. Journal of the American College of Surgeons. 2003;196:1–17
  72. Alayash AI. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?. Nature Biotechnology. 1999;17:545–549
  73. Habler OP, Kleen MS, Pape A, et al. Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis. Critical Care Medicine. 2000;28:1889–1898
  74. Nolte D, Steinhauser P, Pickelmann S, et al. Effects of diaspirin-cross-linked hemoglobin (DCLHb) on local tissue oxygen tension in striated skin muscle: an efficacy study in the hamster. The Journal of Laboratory and Clinical Medicine. 1997;130:328–338
  75. Schultz SC, Hamilton INJ, Malcolm DS. Use of base deficit to compare resuscitation with lactated Ringer's solution, Haemaccel, whole blood, and diaspirin cross-linked hemoglobin following hemorrhage in rats. The Journal of Trauma. 1993;35:619–625
  76. Sprung J, Mackenzie CF, Barnas GM, et al. Oxygen transport and cardiovascular effects of resuscitation from severe hemorrhagic shock using hemoglobin solutions. Critical Care Medicine. 1995;23:1540–1553
  77. Johnson JL, Moore EE, Gonzalez RJ, et al. Alteration of the postinjury hyperinflammatory response by means of resuscitation with a red cell substitute. The Journal of Trauma. 2003;54:133–139
  78. Pickelmann S, Nolte D, Leiderer R, et al. Attenuation of postischemic reperfusion injury in striated skin muscle by diaspirin-cross-linked Hb. The American Journal of Physiology. 1998;275:H361–H368
  79. Botzlar A, Nolte D, Messmer K. Effects of ultra-purified polymerized bovine hemoglobin on the microcirculation of striated skin muscle in the hamster. European Journal of Medical Research. 1996;1:471–478
  80. Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA: The Journal of the American Medical Association. 1999;282:1857–1864
  81. Sloan EP, Koenigsberg M, Brunett PH, et al. Post hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock. The Journal of Trauma. 2002;52:887–895
  82. Gould SA, Moore EE, Hoyt DB, et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. Journal of the American College of Surgeons. 2002;195:445–452
  83. Cheng DC, Mazer CD, Martineau R, et al. A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery. The Journal of Thoracic and Cardiovascular Surgery. 2004;127:79–86
  84. Greenburg AG, Kim HW. Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery. Journal of the American College of Surgeons. 2004;198:373–383
  85. Garrioch MA, McClure JH, Wildsmith JA. Haemodynamic effects of diaspirin crosslinked haemoglobin (DCLHb) given before abdominal aortic aneurysm surgery. British Journal of Anaesthesia. 1999;83:702–707
  86. Kasper SM, Walter M, Grune F, et al. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesthesia and Analgesia. 1996;83:921–927
  87. Lamy ML, Daily EK, Brichant JF, et al. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology. 2000;92:646–656
  88. Schubert A, Przybelski RJ, Eidt JF, et al. Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial. Anesthesia and Analgesia. 2003;97:323–332
  89. Hayes JK, Stanley TH, Lind GH, et al. A double-blind study to evaluate the safety of recombinant human hemoglobin in surgical patients during general anesthesia. Journal of Cardiothoracic and Vascular Anesthesia. 2001;15:593–602
  90. Sprung J, Kindscher JD, Wahr JA, et al. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial. Anesthesia and Analgesia. 2002;94:799–808
  91. Kazmierczak SC, Catrou PG, Best AE, et al. Multiple regression analysis of interference effects from a hemoglobin-based oxygen carrier solution. Clinical Chemistry and Laboratory Medicine. 1999;37:453–464
  92. Mullon J, Giacoppe G, Clagett C, et al. Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia. The New England Journal of Medicine. 2000;342:1638–1643
  93. Lanzkron S, Moliterno AR, Norris EJ, et al. Polymerized human Hb use in acute chest syndrome: a case report. Transfusion. 2002;42:1422–1427
  94. Pape A, Kleen MS, Kemming GI, et al. Fluid resuscitation from severe hemorrhagic shock using diaspirin cross-linked hemoglobin fails to improve pancreatic and renal perfusion. Acta Anaesthesiologica Scandinavica. 2004;48:1328–1337
  95. Pape A, Kemming GI, Meisner FG, et al. Diaspirin cross-linked hemoglobin fails to improve left ventricular diastolic function after fluid resuscitation from hemorrhagic shock. European Surgical Research. 2001;33:318–326
  96. Vandegriff KD, Malavalli A, Wooldridge J, et al. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion. 2003;43:509–516
  97. Wettstein R, Tsai AG, Erni D, et al. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Critical Care Medicine. 2003;31:1824–1830
  98. Winslow RM. Current status of oxygen carriers (‘blood substitutes’): 2006. Vox Sanguinis. 2006;91:102–110
  99. van Woerkens EC, Trouwborst A, van Lanschot JJ. Profound hemodilution: what is the critical level of hemodilution at which oxygen delivery-dependent oxygen consumption starts in an anesthetized human?. Anesthesia and Analgesia. 1992;75:818–821
  100. Kemming GI, Meisner FG, Kleen MS, et al. Hyperoxic ventilation at the critical haematocrit. Resuscitation. 2003;56:289–297
  101. Meisner FG, Kemming GI, Habler OP, et al. Diaspirin crosslinked hemoglobin enables extreme hemodilution beyond the critical hematocrit. Critical Care Medicine. 2001;29:829–838

PII: S1521-6896(07)00020-1

doi: 10.1016/j.bpa.2007.02.004

Best Practice & Research Clinical Anaesthesiology
Volume 21, Issue 2 , Pages 221-239 , June 2007

Article Tools

* Image Usage & Resolution